the week, big U.S. drug makers raised their forecasts for the year based on favorable exchange rates. Eli Lilly & Co (LLY.N JPMorgan analyst Chris Schott said the weak dollar should prop up the drugmakers for the remainder of the year.[ID:nN18184252]...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to WRAPUP 1-Weak dollar helps earnings, but little hiring yet
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account